ArticleThe Journal of investigative dermatology2024

Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.

Bobby B Shih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.